Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

366 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial.
Schuler M, Cuppens K, Plönes T, Wiesweg M, Du Pont B, Hegedus B, Köster J, Mairinger F, Darwiche K, Paschen A, Maes B, Vanbockrijck M, Lähnemann D, Zhao F, Hautzel H, Theegarten D, Hartemink K, Reis H, Baas P, Schramm A, Aigner C. Schuler M, et al. Among authors: aigner c. Nat Med. 2024 Jun;30(6):1602-1611. doi: 10.1038/s41591-024-02965-0. Epub 2024 Apr 30. Nat Med. 2024. PMID: 38689060 Free PMC article. Clinical Trial.
High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer.
Wiesweg M, Eberhardt WEE, Reis H, Ting S, Savvidou N, Skiba C, Herold T, Christoph DC, Meiler J, Worm K, Kasper S, Theegarten D, Hense J, Hager T, Darwiche K, Oezkan F, Aigner C, Welter S, Kühl H, Stuschke M, Schmid KW, Schuler M. Wiesweg M, et al. Among authors: aigner c. J Thorac Oncol. 2017 Jan;12(1):54-64. doi: 10.1016/j.jtho.2016.08.137. Epub 2016 Aug 27. J Thorac Oncol. 2017. PMID: 27575422 Free article.
KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis.
Lohinai Z, Klikovits T, Moldvay J, Ostoros G, Raso E, Timar J, Fabian K, Kovalszky I, Kenessey I, Aigner C, Renyi-Vamos F, Klepetko W, Dome B, Hegedus B. Lohinai Z, et al. Among authors: aigner c. Sci Rep. 2017 Jan 4;7:39721. doi: 10.1038/srep39721. Sci Rep. 2017. PMID: 28051122 Free PMC article.
Same-day Routine Chest-X Ray After Thoracic Surgery is Not Necessary!
Nagy P, Antony C, Hegedüs B, Kampe S, Ploenes T, Aigner C, Welter S. Nagy P, et al. Among authors: aigner c. Zentralbl Chir. 2018 Feb;143(1):96-101. doi: 10.1055/s-0043-117174. Epub 2017 Sep 13. Zentralbl Chir. 2018. PMID: 28905345 English.
Pulmonary metastasectomy for sarcoma-Essen experience.
Gafencu DA, Welter S, Cheufou DH, Ploenes T, Stamatis G, Stuschke M, Theegarten D, Taube C, Bauer S, Aigner C. Gafencu DA, et al. Among authors: aigner c. J Thorac Dis. 2017 Oct;9(Suppl 12):S1278-S1281. doi: 10.21037/jtd.2017.07.47. J Thorac Dis. 2017. PMID: 29119015 Free PMC article.
Oleothorax.
Plönes T, Aigner C. Plönes T, et al. Among authors: aigner c. Thorax. 2018 Aug;73(8):791. doi: 10.1136/thoraxjnl-2017-210544. Epub 2018 Jan 29. Thorax. 2018. PMID: 29382798 No abstract available.
366 results